1. Home
  2. EYE vs BHVN Comparison

EYE vs BHVN Comparison

Compare EYE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$18.81

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$15.64

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
BHVN
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
EYE
BHVN
Price
$18.81
$15.64
Analyst Decision
Strong Buy
Buy
Analyst Count
9
14
Target Price
$31.22
$29.08
AVG Volume (30 Days)
2.3M
3.6M
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
202.78
26.08
EPS
0.38
N/A
Revenue
$1,987,488,000.00
N/A
Revenue This Year
$5.56
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$47.47
N/A
Revenue Growth
9.00
N/A
52 Week Low
$14.75
$7.48
52 Week High
$30.02
$18.57

Technical Indicators

Market Signals
Indicator
EYE
BHVN
Relative Strength Index (RSI) 55.54 73.82
Support Level $14.84 $14.83
Resistance Level $19.18 $15.71
Average True Range (ATR) 0.95 0.99
MACD 0.36 0.36
Stochastic Oscillator 87.86 81.19

Price Performance

Historical Comparison
EYE
BHVN

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: